Wholesalers, Stiefel clash over Zuellig issue

Published: 2008-09-12 07:00:00

Updated: 2008-09-12 07:00:00

The ever-increasing strife between pharmaceutical wholesalers and Stiefel Korea will be likely to deepen as Stiefel headquarters dismissed the request of Stiefel Korea, saying it is against its global policy.

Stiefel Korea decided to outsource its medicines to Zuellig Korea, inviting the stron...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK